MicroRNAs in Pancreatic Cancer: Insights from a Mouse Model
Author Information
Author(s): Joseph J. LaConti, Narayan Shivapurkar, Anju Deslattes, Anne Wellstein, Ivana Kim, Sung Eun Marshall, John L. Riegel, Anna T. Wellstein
Primary Institution: Lombardi Cancer Center, Georgetown University
Hypothesis
Circulating microRNAs could provide insight into pathways altered during cancer progression and may indicate responses to treatment.
Conclusion
The study found that changes in microRNA expression patterns during the progression of pancreatic cancer in a mouse model mirrored those observed in human pancreatic cancer tissues.
Supporting Evidence
- MicroRNA expression patterns in the mouse model were similar to those in human pancreatic cancer tissues.
- Circulating microRNAs could serve as indicators of drug response.
- Gemcitabine treatment caused significant changes in circulating microRNA levels.
Takeaway
This study looked at tiny molecules called microRNAs in mice with pancreatic cancer to see if they could help us understand the disease and how well treatments work.
Methodology
The study used a genetically engineered mouse model to analyze microRNA expression in pancreatic tissues and plasma samples from patients.
Potential Biases
Potential bias in the selection of microRNAs and the interpretation of their roles in cancer progression.
Limitations
The study primarily focused on a specific mouse model and may not fully represent human pancreatic cancer complexities.
Participant Demographics
Included patients with pancreatic cancer and other gastrointestinal cancers.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website